BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savić-gajić IM, Savić IM. Drug design strategies with metal-hydroxyquinoline complexes. Expert Opinion on Drug Discovery 2020;15:383-90. [DOI: 10.1080/17460441.2020.1702964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ali Drweesh E, Vilková M, Elnagar MM, Potočňák I. Low-dimensional compounds containing bioactive ligands. Part XVIII: Design, synthesis and crystal structural investigations of ionic heteroleptic Pd(II) complexes based on halo and nitro 8-hydroxyquinoline derivatives. Polyhedron 2022;219:115800. [DOI: 10.1016/j.poly.2022.115800] [Reference Citation Analysis]
2 Dömötör O, Keppler BK, Enyedy ÉA. Solution speciation and human serum protein binding of indium(III) complexes of 8-hydroxyquinoline, deferiprone and maltol. J Biol Inorg Chem 2022. [PMID: 35243522 DOI: 10.1007/s00775-022-01935-6] [Reference Citation Analysis]
3 Domińska M, Pastuch-Gawołek G, Domiński A, Kurcok P, Erfurt K. Synthesis and Preliminary Evaluation of the Cytotoxicity of Potential Metabolites of Quinoline Glycoconjugates. Molecules 2022;27:1040. [PMID: 35164304 DOI: 10.3390/molecules27031040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lichitsky BV, Komogortsev AN, Melekhina VG. 2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic Acid. Molbank 2022;2022:M1315. [DOI: 10.3390/m1315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Meiss CJ, Bothwell PJ, Webb MI. Ruthenium(II)–arene complexes with chelating quinoline ligands as anti-amyloid agents. Can J Chem 2022;100:18-24. [DOI: 10.1139/cjc-2021-0180] [Reference Citation Analysis]
6 Southcott L, Orvig C. Inorganic radiopharmaceutical chemistry of oxine. Dalton Trans 2021;50:16451-8. [PMID: 34709268 DOI: 10.1039/d1dt02685b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Bouvry C, Ardisson V, Noiret N, Garin E, Lepareur N. Labeling of Hinokitiol with 90Y for Potential Radionuclide Therapy of Hepatocellular Carcinoma. Processes 2021;9:940. [DOI: 10.3390/pr9060940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Krawczyk M, Pastuch-Gawołek G, Hadasik A, Erfurt K. 8-Hydroxyquinoline Glycoconjugates Containing Sulfur at the Sugar Anomeric Position-Synthesis and Preliminary Evaluation of Their Cytotoxicity. Molecules 2020;25:E4174. [PMID: 32933091 DOI: 10.3390/molecules25184174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Domiński A, Krawczyk M, Konieczny T, Kasprów M, Foryś A, Pastuch-Gawołek G, Kurcok P. Biodegradable pH-responsive micelles loaded with 8-hydroxyquinoline glycoconjugates for Warburg effect based tumor targeting. Eur J Pharm Biopharm 2020;154:317-29. [PMID: 32717390 DOI: 10.1016/j.ejpb.2020.07.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]